This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Alan I. Faden, MD

JAMA. 1996;276(7):569-570.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the past several years, results of clinical trials have generated considerable optimism about the prospects for effective treatment of acute central nervous system (CNS) injuries. A multicenter trial demonstrated the effectiveness of methylprednisolone, as well as naloxone hydrochloride, in improving neurologic recovery after spinal cord injury.¹ In ischemic stroke, early treatment with tissue plasminogen activator² or treatment with low-molecular-weight heparin³ led to improved outcome for some patients. To date, however, no effective pharmacotherapy has been developed for head injury.

One of the more promising experimental strategies for treatment of acute CNS injury has been the use of antioxidants or free-radical scavengers. This approach is based on the concept that oxygen free radicals are generated in response to the insult, thereby overwhelming endogenous antioxidant or free radical-scavenging systems such as superoxide dismutase (SOD), catalase, glutathione, ascorbic acid, and -tocopherol.^4,5 Free radicals are believed to contribute to . . . [Full Text PDF of this Article]

Author Affiliations
From the Institute for Cognitive and Computational Sciences, Georgetown University Medical Center, Washington, DC.

Footnotes
Reprints: Alan I. Faden, MD, Georgetown University Medical Center, Institute for Cognitive and Computational Sciences, Research Building, 3970 Reservoir Road NW, Washington, DC 20007.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?